{"id":2128,"date":"2022-01-21T10:15:14","date_gmt":"2022-01-21T13:15:14","guid":{"rendered":"https:\/\/ri-alliar2020.mz-sites.com\/noticias\/aprovacao-cade\/"},"modified":"2022-07-04T15:30:10","modified_gmt":"2022-07-04T18:30:10","slug":"cade-approval","status":"publish","type":"noticias","link":"https:\/\/ri.allianca.com\/en\/noticias\/cade-approval\/","title":{"rendered":"CADE Approval"},"content":{"rendered":"
\n
CENTRO DE IMAGEM DIAGNOSTICS S.A.<\/strong>\u00a0(“Company”) (B3: AALR3) ), in compliance with paragraph 4 of article 157 of Law 6404\/76 and Instruction 44\/2021 of the Brazilian Securities and Exchange Commission (“CVM”), informs its shareholders and the market in general that the Administrative Council for Economic Defense (“CADE”) approved, on January 20, 2022, without restrictions, the transaction between Fonte de Sa\u00fade Fundo de Investimento em Participa\u00e7\u00f5es Multiestrat\u00e9gia (“MAM”) and signatories of the shareholders\u2018 agreement entered into on August 20, 2021, as amended (“Controlling Shareholders”), object of the Material Facts disclosed by the Company on November 18, 2021, November 26, 2021 and December 21, 2021 (“Transaction”). The decision will only be final after a period of 15 days from its publication in the Federal Official Gazette (“Di\u00e1rio Oficial da Uni\u00e3o”), which took place on this date, has elapsed, without any appeals by the CADE Court, under the terms of the applicable legislation. The closing of the Transaction still awaits the completion of other normal conditions precedent for this type of transaction, which will be communicated by the parties to the Company as soon as they are fulfilled.<\/p>\n

 <\/p>\n

The Company reiterates its commitment to keep the market informed about relevant facts and acts, in compliance with applicable regulations.<\/p>\n

 <\/p>\n

S\u00e3o Paulo, January 21, 2022.<\/p>\n

To access the full document,\u00a0click here<\/a>.<\/p>\n

Karla Maciel<\/strong>
\nCFO & IRO
\nE-mail:\u00a0ri@alliar.com<\/a><\/p>\n

 <\/p>\n<\/section>\n

<\/div>\n<\/section>\n
<\/div>\n","protected":false},"featured_media":0,"template":"","class_list":["post-2128","noticias","type-noticias","status-publish","hentry"],"yoast_head":"\nCADE Approval - Allian\u00e7a RI<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ri.allianca.com\/en\/noticias\/cade-approval\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CADE Approval - Allian\u00e7a RI\" \/>\n<meta property=\"og:description\" content=\"CENTRO DE IMAGEM DIAGNOSTICS S.A.\u00a0(“Company”) (B3: AALR3) ), in compliance with paragraph 4 of article 157 of Law 6404\/76 and Instruction 44\/2021 of the Brazilian Securities and Exchange Commission (“CVM”), informs its shareholders and the market in general that the Administrative Council for Economic Defense (“CADE”) approved, on January 20, 2022, without restrictions, the transaction […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ri.allianca.com\/en\/noticias\/cade-approval\/\" \/>\n<meta property=\"og:site_name\" content=\"Allian\u00e7a RI\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-04T18:30:10+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ri.allianca.com\/en\/noticias\/cade-approval\/\",\"url\":\"https:\/\/ri.allianca.com\/en\/noticias\/cade-approval\/\",\"name\":\"CADE Approval - Allian\u00e7a RI\",\"isPartOf\":{\"@id\":\"https:\/\/ri.allianca.com\/#website\"},\"datePublished\":\"2022-01-21T13:15:14+00:00\",\"dateModified\":\"2022-07-04T18:30:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ri.allianca.com\/en\/noticias\/cade-approval\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ri.allianca.com\/en\/noticias\/cade-approval\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ri.allianca.com\/en\/noticias\/cade-approval\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/ri.allianca.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CADE Approval\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ri.allianca.com\/#website\",\"url\":\"https:\/\/ri.allianca.com\/\",\"name\":\"Allian\u00e7a RI\",\"description\":\"Rela\u00e7\u00f5es com Investidores\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ri.allianca.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CADE Approval - Allian\u00e7a RI","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ri.allianca.com\/en\/noticias\/cade-approval\/","og_locale":"en_US","og_type":"article","og_title":"CADE Approval - Allian\u00e7a RI","og_description":"CENTRO DE IMAGEM DIAGNOSTICS S.A.\u00a0(“Company”) (B3: AALR3) ), in compliance with paragraph 4 of article 157 of Law 6404\/76 and Instruction 44\/2021 of the Brazilian Securities and Exchange Commission (“CVM”), informs its shareholders and the market in general that the Administrative Council for Economic Defense (“CADE”) approved, on January 20, 2022, without restrictions, the transaction […]","og_url":"https:\/\/ri.allianca.com\/en\/noticias\/cade-approval\/","og_site_name":"Allian\u00e7a RI","article_modified_time":"2022-07-04T18:30:10+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ri.allianca.com\/en\/noticias\/cade-approval\/","url":"https:\/\/ri.allianca.com\/en\/noticias\/cade-approval\/","name":"CADE Approval - Allian\u00e7a RI","isPartOf":{"@id":"https:\/\/ri.allianca.com\/#website"},"datePublished":"2022-01-21T13:15:14+00:00","dateModified":"2022-07-04T18:30:10+00:00","breadcrumb":{"@id":"https:\/\/ri.allianca.com\/en\/noticias\/cade-approval\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ri.allianca.com\/en\/noticias\/cade-approval\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ri.allianca.com\/en\/noticias\/cade-approval\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/ri.allianca.com\/en\/"},{"@type":"ListItem","position":2,"name":"CADE Approval"}]},{"@type":"WebSite","@id":"https:\/\/ri.allianca.com\/#website","url":"https:\/\/ri.allianca.com\/","name":"Allian\u00e7a RI","description":"Rela\u00e7\u00f5es com Investidores","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ri.allianca.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/ri.allianca.com\/en\/wp-json\/wp\/v2\/noticias\/2128","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ri.allianca.com\/en\/wp-json\/wp\/v2\/noticias"}],"about":[{"href":"https:\/\/ri.allianca.com\/en\/wp-json\/wp\/v2\/types\/noticias"}],"wp:attachment":[{"href":"https:\/\/ri.allianca.com\/en\/wp-json\/wp\/v2\/media?parent=2128"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}